Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 3
Submit an article Journal homepage
45
Views
23
CrossRef citations to date
0
Altmetric
Research Article

The Role of Soluble CD23 in Distinguishing Stable and Progressive Forms of B-chronic Lymphocytic Leukemia

Josef D. Schwarzmeier Department of Hematology, Clinic of Internal Medicine I, University of Vienna
,
Medhat Shehata Department of Hematology, Clinic of Internal Medicine I, University of Vienna
,
Martin Hilgarth Department of Hematology, Clinic of Internal Medicine I, University of Vienna
,
Ingrid Marschitz Department of Hematology and Oncology, University of Innsbruck, Internal Medicine, A-6020 Innsbruck, Austria
,
Norbert Louda Department of Hematology, Clinic of Internal Medicine I, University of Vienna
,
Rainer Hubmann L. Boltzmann Institute for Cytokine Research, University of Vienna, P.O. Box 16, Waehringer Guertel 18-20, A-1097, Vienna, Austria
&
Richard Greil Department of Hematology and Oncology, University of Innsbruck, Internal Medicine, A-6020 Innsbruck, Austria
 show all
Pages 549-554 | Published online: 01 Jul 2009

  • Zwiebel, J.A. and Cheson, B.D. (1998) "Chronic lymphocytic leukemia: staging and prognostic factors", Semin. Oncol. 25, 42-59.
  • Gonzalez, M.A. and Spiegelberg, H.L. (1977) "A subpopulalion of normal human peripheral B lymphocytes that hind IgE", J. Clin. Invest. 59, 616-624.
  • Kintner, C. and Sugden, B. (1981) "Identification of antigenic determinants unique to the surfaces of cells transformed by Epstein-Barr virus", Nature 294, 458-460.
  • Thorley, L.D., Nadler, L.M., Bhan, A.K. and Schooley, R. T. (1985) "BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus", J. Immunol. 134, 3007-3012.
  • Letellier, M., Nakajima, T., Pulido, C.G., Hofstetter, H. and Delespesse, G. (1990) "Mechanism of formation of human IgE-binding factors (soluble CD23): III. Evidence for a receptor (Fe epsilon RII)-associated proteolytic activity", J, Exp. Med. 172, 693-700.
  • Delespesse, G., Sarfati, M., Wu, C.Y. Foumier, S. and Letellier, M. (1992) "The low-affinity receptor for IgE", Immynol. Rev. 125, 77-97.
  • Sarfati, M., Bron, D. Lagneaux, L., Fonteyn, C., Frost, H. and Delespesse, G. (1988) "Elevation of IgE-binding factors in serum of patients with B cell-derived chronic lymphocytic leukemia", Blood 71, 94-98.
  • Reinisch, W., Willheim, M., Hilgarth, M., Gasche, C., Mader, R., Szepfalusi, S., Steger, G., Berger, R., Lechner, K., Boltz, N.G. and Schwarzmeier, J.D. (1994) "Soluble CD13 reliably reflects disease activity in B-cell chronic lymphocytic leukemia", J. Clin, Oncol. 12, 2146-2152.
  • Molica, S., Levato, D., Dell'Olio, M., Matera, R., Minervini, M., Dattilo, A., Carotenuto, M. and Musto, P. (1996) "Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia Implications for prognosis", Haematologica 81, 428-433.
  • Sarfati, M., Chevret, S., Chastang, C., Biron, C., Stryckmans, P., Delespesse, G., Binet, J.L., Merle, B.H. and Bron, D. (1996) "Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia", Blood 88, 4259-4264.
  • Knauf, W.U., Langenmayer, I., Ehlers, B., Mohr, B., Adorf, D., Nerl, C.H., Hallek, M., Zwingers, T.H., Emmerich, B. and Thiel, E. (1997) "Serum levels of soluble CD23, but not soluble CD25. predict disease progression in early stage B-cell chronic lymphocytic leukemia", Leuk. Lymphoma. 27, 523-532.
  • Dighiero, G. and Binet, J.L. (2000) "When and how to treat chronic lymphocytic leukemia", N. Engl. J. Med. 343, 1799-1801.
  • Rozman, C. and Montserrat, E. (1995) "Chronic lymphocytic leukemia", N. Eng. J. Med. 333, 1052-1057.
  • Dohner, H., Stilgenbauer, S., Dohner, K., Bentz, M. and Lichter, P. (1999) "Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis", J. Mol. Med. 77, 266-281.
  • Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. and Chiorazzi, N. (1999) "Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia", Blood 94, 1840-1847.
  • Rai, K.R., Sawitsky, A., Cronkite, K.P., Chanana, A.D., Levy, R.N. and Pastenack, B.S. (1975) "Clinical staging of chronic lymphocytic leukemia", Blood 46, 219-234.
  • Montserrat, K., Sanchez, B.J., Vinolas, N. and Rozman, C. (1986) "Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance", Br. J. Haematol, 62, 567-575.
  • Gagro, A., Dasic, G., Sabioncello, A., Rabatic, S., Reckzeh, B., Havemann, K., Kardum, I., Jacksic, B. and Vitale, B. (1997) "Phenotypic analysis of receptor-ligand pairs on B-chronic lymphocytic leukemia", Leuk. Lymphoma. 25, 301-311.
  • Molica, S., Levato, D., Cascavilla, N., Levato, L. and Musto, P. (1999) "Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and beta2-microglobulin in B-cell chronic lymphocytic leukemia", Eur. J. Haematol. 62, 117-122.
  • Beguin, Y. Lampertz, S., De, G.D., Igot, D., Malaise, M. and Fillet, G. (1993) "Soluble CD23 and other receptors (CD4 CDS, CD25, CD71) in serum of patients with chronic lymphocytic leukemia", Leukemia 7, 2019-2025.
  • Hallek, M., Langenmayer, I., Nerl, C., Knauf, W., Dietzfelbinger, H., Adorf, D., Oslwald, M., Busch, R., Kuhn, H.I., Thiel, E. and Emmerich, B. (1999) "Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia", Blood 93, 1732-1737.
  • Digel, W., Ponzsolt, F., Schmid, M., Herrmann, E, Lesslauer, W. and Brockhaus, M. (1992) "High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia", J. Clin. Invest. 89, 1690-1693.
  • Christiansen, I., Sundstrom, C. and Totterman, T.H. (1998) "Elevated seram levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) closely reflect tumour burden in chronic B-lymphocytic leukaemia", Br, J. Haematol. 103, 1129-1137.
  • Hamblin, T.J., Davis, Z., Gaidiner, A., Oscier, D.G. and Stevenson, F.K. (1999) "Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia", Blood 94, 1848-1854.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.